`

Monday, 19 August 2019

Pharma/BioPharma News

  • Olon completes acquisition of Mahad plant

    Pharma/BioPharma |  News | 0 Comment | 08 Apr, 2019

    OlonS.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has announced the closing of the acquis...Read more

  • Lupin launches Tadalafil Tablets USP

    Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

    Lupin has announced the launch of Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupi...Read more

  • Dr. Reddy’s announces US rights for its dermatology brands

    Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

    Dr. Reddy’s Laboratories Limited, through its wholly owned subsidiary Promius Pharma, LLC, announces the sale of its rights for SERNIVO® (betamethasone dipropionate) Spray, 0...Read more

  • Pulmatrix signs binding agreement with Cipla worth $22M

    Pharma/BioPharma |  News | 0 Comment | 02 Apr, 2019

    Pulmatrix, Inc., a clinical stage biopharmaceutical company focused on developing novel inhaled therapeutics to serve unmet needs in respiratory disease, has announced its entry into a Bind...Read more

  • Novartis to acquire IFM Tre in a $310M deal

    Pharma/BioPharma |  News | 0 Comment | 01 Apr, 2019

    IFM Therapeutics (IFM), a privately held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, announced that it has reached a d...Read more

  • Lupin launches Fluocinonide Ointment USP 0.05%

    Pharma/BioPharma |  News | 0 Comment | 29 Mar, 2019

    Lupin announced the launch of Fluocinonide Ointment USP, 0.05%, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Fluocinonide Oi...Read more

  • Indian Pharma Sector: What Next After Gottlieb?

    Pharma/BioPharma |  News | 0 Comment | 29 Mar, 2019

    Indian drug makers, whose major part of business comes from the sale of generics in the US, received all the encouragement needed when the US Food and Drug Administration (USFDA) Commission...Read more

  • Jubilant Biosys adopts ForteBio's latest SPR System in India

    Pharma/BioPharma |  News | 0 Comment | 28 Mar, 2019

    Jubilant Biosys, a subsidiary of Jubilant Life Sciences Ltd has added advanced Pioneer FE system to its platform of drug discovery solutions available to customers. The Pioneer FE syst...Read more

  • Novartis’ Mayzent gets FDA nod to treat multiple sclerosis

    Pharma/BioPharma |  News | 0 Comment | 27 Mar, 2019

    Novartis has received the US Food and Drug Administration (FDA) approval of Mayzent® (siponimod) for the treatment of adults with relapsing forms of multiple sclerosis, including s...Read more

  • Alembic Pharma set to launch allergic conjunctivitis drug

    Pharma/BioPharma |  News | 0 Comment | 22 Mar, 2019

    Alembic Pharmaceuticals Limited has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Azelastine Hydrochloride Ophthalmic ...Read more

  • Syngene International wins CMO Leadership Awards

    Pharma/BioPharma |  News | 0 Comment | 22 Mar, 2019

    Syngene International Ltd., an innovation focused global discovery, development and manufacturing organization, announced that it has won the CMO Leadership Awards presented by Life Science...Read more

  • Pharmexcil to organize India Pavilion at Korea Pharm

    Pharma/BioPharma |  News | 0 Comment | 21 Mar, 2019

    Pharmaceuticals Export Promotion Council of India (Pharmexcil) is organizing India Pavilion at Korea Pharm, being held at Korea International Exhibition Center (KINTEX), Goyang, South Korea...Read more

  • C2 PHARMA acquires Digoxin API portfolio from Nobilus Ent

    Pharma/BioPharma |  News | 0 Comment | 19 Mar, 2019

    C2 PHARMA s.a.r.l., a phytochemical and chemical pharmaceutical manufacturing and distribution group, has acquired the Digoxin API product portfolio of Polish company, Nobilus Ent...Read more

  • Dr Reddy’s launches advanced service portal for customers

    Pharma/BioPharma |  News | 0 Comment | 19 Mar, 2019

    Dr. Reddy’s Laboratories Ltd. announces the launch of its advanced B2B Customer Service Portal “XCEED.” Fully focused on meeting the growing demand for Dr. Reddy’s p...Read more

  • Zydus set to market generic anti-diabetic drug

    Pharma/BioPharma |  News | 0 Comment | 15 Mar, 2019

    Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies The company has received the tentative...Read more

  • AstraZeneca enters into research collaboration with Seres Therapeutics

    Pharma/BioPharma |  News | 0 Comment | 13 Mar, 2019

    Seres Therapeutics has announced a three-year research collaboration with AstraZeneca. The collaboration will focus on advancing mechanistic understanding of the microbiome in augmenti...Read more

  • Piramal launches Cinacalcet in the US market

    Pharma/BioPharma |  News | 0 Comment | 12 Mar, 2019

    Piramal Enterprises Limited has announced that one of its partners for its global pharma businesses - Slate Run Pharmaceuticals LLC. (‘Slate Run’), has launched generic cinacalc...Read more

  • West opens new digital technology centre in India

    Pharma/BioPharma |  News | 0 Comment | 08 Mar, 2019

    West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, has officially opened the Company’s new Digital Technology centre (DTC)...Read more